Anna Berg

1.1k total citations
21 papers, 683 citations indexed

About

Anna Berg is a scholar working on Obstetrics and Gynecology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Anna Berg has authored 21 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Obstetrics and Gynecology, 9 papers in Molecular Biology and 9 papers in Reproductive Medicine. Recurrent topics in Anna Berg's work include Endometrial and Cervical Cancer Treatments (10 papers), Ovarian cancer diagnosis and treatment (7 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Anna Berg is often cited by papers focused on Endometrial and Cervical Cancer Treatments (10 papers), Ovarian cancer diagnosis and treatment (7 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Anna Berg collaborates with scholars based in Norway, United States and Thailand. Anna Berg's co-authors include Camilla Krakstad, Jone Trovik, Helga B. Salvesen, Ingvild L. Tangen, Mari K. Halle, Henrica M.J. Werner, Erling A. Høivik, Kanthida Kusonmano, Margrét Árnadóttir and Peter Nilsson‐Ehle and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Anna Berg

21 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Berg Norway 16 287 256 184 167 150 21 683
Alejandro Rojo‐Sebastián Spain 14 375 1.3× 200 0.8× 142 0.8× 122 0.7× 114 0.8× 18 686
Norbert Drieschner Germany 12 206 0.7× 238 0.9× 219 1.2× 53 0.3× 121 0.8× 20 608
Donna Dunn United States 5 170 0.6× 95 0.4× 98 0.5× 145 0.9× 93 0.6× 5 494
Taren Johnston United States 7 264 0.9× 259 1.0× 199 1.1× 120 0.7× 78 0.5× 9 638
Janusz Menkiszak Poland 17 399 1.4× 87 0.3× 232 1.3× 172 1.0× 185 1.2× 50 853
Morio Sawada Japan 14 304 1.1× 158 0.6× 85 0.5× 124 0.7× 106 0.7× 25 606
Linn Woelber Germany 14 138 0.5× 110 0.4× 299 1.6× 150 0.9× 90 0.6× 23 479
Ritsuto Fujiwaki Japan 17 357 1.2× 206 0.8× 196 1.1× 215 1.3× 206 1.4× 55 834
Sabine Kotschan Austria 5 313 1.1× 62 0.2× 39 0.2× 99 0.6× 127 0.8× 5 521
Naoki Ogane Japan 14 205 0.7× 72 0.3× 104 0.6× 116 0.7× 160 1.1× 26 437

Countries citing papers authored by Anna Berg

Since Specialization
Citations

This map shows the geographic impact of Anna Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Berg more than expected).

Fields of papers citing papers by Anna Berg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Berg. The network helps show where Anna Berg may publish in the future.

Co-authorship network of co-authors of Anna Berg

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Berg. A scholar is included among the top collaborators of Anna Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Berg. Anna Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Røsland, Gro Vatne, Sissel E. Dyrstad, Deusdedit Tusubira, et al.. (2019). Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC. SHILAP Revista de lepidopterología. 7(1). 6–6. 56 indexed citations
2.
Holst, Frederik, Henrica M.J. Werner, Siv Mjøs, et al.. (2018). PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma. Clinical Cancer Research. 25(1). 334–345. 21 indexed citations
3.
Kusonmano, Kanthida, Mari K. Halle, Elisabeth Wik, et al.. (2018). Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer. PLoS ONE. 13(11). e0206665–e0206665. 9 indexed citations
4.
Halle, Mari K., Ingvild L. Tangen, Hege F. Berg, et al.. (2017). HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. British Journal of Cancer. 118(3). 378–387. 57 indexed citations
5.
Berg, Hege F., Per‐Henrik Edqvist, Anna Berg, et al.. (2017). Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions. Gynecologic Oncology. 148(1). 197–203. 16 indexed citations
6.
Mjøs, Siv, Henrica M.J. Werner, Even Birkeland, et al.. (2017). PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer. Scientific Reports. 7(1). 10240–10240. 23 indexed citations
7.
Berg, Anna, Sigmund Ytre‐Hauge, Kristine E. Fasmer, et al.. (2017). Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers. Oncotarget. 8(40). 68530–68541. 4 indexed citations
8.
Mauland, Karen K., Zhenlin Ju, Ingvild L. Tangen, et al.. (2017). Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients. Oncotarget. 8(63). 106989–107001. 8 indexed citations
9.
Mauland, Karen K., Sigmund Ytre‐Hauge, Ingvild L. Tangen, et al.. (2017). High visceral fat percentage is associated with poor outcome in endometrial cancer. Oncotarget. 8(62). 105184–105195. 37 indexed citations
10.
Mauland, Karen K., Elisabeth Wik, Erling A. Høivik, et al.. (2016). Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival. Oncotarget. 8(6). 9696–9707. 3 indexed citations
11.
Tangen, Ingvild L., Reidun Kopperud, Anna Berg, et al.. (2016). Androgen receptor as potential therapeutic target in metastatic endometrial cancer. Oncotarget. 7(31). 49289–49298. 56 indexed citations
12.
Berg, Anna, Kristine E. Fasmer, Karen K. Mauland, et al.. (2016). Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer. Oncotarget. 7(43). 69844–69856. 31 indexed citations
13.
Krakstad, Camilla, Ingvild L. Tangen, Erling A. Høivik, et al.. (2015). ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma. Oncotarget. 6(29). 28440–28452. 38 indexed citations
14.
Tangen, Ingvild L., Henrica M.J. Werner, Anna Berg, et al.. (2014). Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions. European Journal of Cancer. 50(17). 3003–3010. 61 indexed citations
15.
Martín, Yusé, et al.. (2014). Dub3 controls DNA damage signalling by direct deubiquitination of H2AX. Molecular Oncology. 8(5). 884–893. 35 indexed citations
16.
Høivik, Erling A., Kanthida Kusonmano, Mari K. Halle, et al.. (2014). Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. Oncotarget. 5(4). 1052–1061. 29 indexed citations
17.
Haldorsen, Ingfrid S., Anna Berg, Henrica M.J. Werner, et al.. (2012). Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas. Gynecologic Oncology. 126(3). 413–418. 17 indexed citations
18.
Werner, Henrica M.J., Anna Berg, Elisabeth Wik, et al.. (2012). ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. Modern Pathology. 26(3). 428–434. 62 indexed citations
19.
Berg, Anna, Arnar Rafnsson, Magnús Jóhannsson, Björn Hultberg, & Margrét Árnadóttir. (2006). The effects of adrenocorticotrophic hormone and cortisol on homocysteine and vitamin B concentrations. Clinical Chemistry and Laboratory Medicine (CCLM). 44(5). 628–31. 9 indexed citations
20.
Berg, Anna, Peter Nilsson‐Ehle, & Margrét Árnadóttir. (1999). Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy. Kidney International. 56(4). 1534–1543. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026